Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma

Clinical trial NCT04303897 · COMPLETED

Trial details

NCT number: NCT04303897
Sponsor: Allergan
Status: COMPLETED
Study type: OBSERVATIONAL

Refractory Glaucoma

Start date: 2019-12-19
Primary completion: 2022-03-03
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.